Literature DB >> 28242273

Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.

E Dyakova1, K N Bisnauthsing2, A Querol-Rubiera2, A Patel2, C Ahanonu2, O Tosas Auguet2, J D Edgeworth2, S D Goldenberg2, J A Otter3.   

Abstract

OBJECTIVES: We evaluated 'pre-laboratory' factors associated with the detection of extended spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) colonization including anatomical site, and staff and patient factors.
METHODS: All admissions to a large London hospital over 3 months were approached to provide rectal and perineal swabs, which were cultured for ESBL-E using chromogenic media. ESBL-E detection rates for patient- or staff-collected rectal or perineal swabs were compared using McNemar tests. Binary logistic regression was used to explore factors associated with patients declining to provide a rectal swab. The impact of simplifying the verbal study description to patients to improve the participation rate was evaluated.
RESULTS: Carriage of ESBL-E was significantly higher in rectal swabs than perineal swabs (7.8% of 4006 versus 3.8% of 4006, p <0.001), whether collected by staff or patients; 31.9% of 869 patients did not provide a rectal swab before the change in study description compared with 7.6% of 3690 patients afterwards (p <0.001). In multivariable analysis, factors associated with patients declining to provide a rectal swab were younger age (OR 0.99, 95% CI 0.99-1.00), female gender (OR 1.26, 95% CI 1.04-1.52), transfers from other hospitals (OR 1.77, 95% CI 1.07-2.93) or an unknown admission route (OR 1.61, 95% CI 1.09-2.37), being admitted before the change in study description (OR 0.39, 95% CI 0.31-0.48), and the staff member who consented the patient (p <0.001); ethnicity was not a significant factor.
CONCLUSIONS: Rectal swabs are recommended for the detection of ESBL-E colonization. Staff and patient factors influence whether patients participate in prevalence studies, which may skew their findings.
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colonization; Diagnostic sensitivity; Extended spectrum β-lactamase; Patient acceptability; Screening; Staff acceptability; Surveillance cultures

Mesh:

Substances:

Year:  2017        PMID: 28242273     DOI: 10.1016/j.cmi.2017.02.019

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  The acceptability of screening for Carbapenemase Producing Enterobacteriaceae (CPE): cross-sectional survey of nursing staff and the general publics' perceptions.

Authors:  Kay Currie; Caroline King; Kareena McAloney-Kocaman; Nicola J Roberts; Jennifer MacDonald; Adele Dickson; Shona Cairns; Nitish Khanna; Paul Flowers; Jacqui Reilly; Lesley Price
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-23       Impact factor: 4.887

2.  Extended spectrum beta-lactamase producing Enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.

Authors:  Renaud Prevel; Alexandre Boyer; Fatima M'Zali; Thibaut Cockenpot; Agnes Lasheras; Véronique Dubois; Didier Gruson
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-10       Impact factor: 4.887

3.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Neonatal Foals: Prevalence, Risk Factors for Shedding and Association with Infection.

Authors:  Anat Shnaiderman-Torban; Yossi Paitan; Haia Arielly; Kira Kondratyeva; Sharon Tirosh-Levy; Gila Abells-Sutton; Shiri Navon-Venezia; Amir Steinman
Journal:  Animals (Basel)       Date:  2019-08-23       Impact factor: 2.752

4.  Early and Late Efficacy on Wound Healing of Silver Nanoparticle Gel in Males after Circumcision.

Authors:  Matteo Balzarro; Emanuele Rubilotta; Nicolò Trabacchin; Antonio Soldano; Clara Cerrato; Filippo Migliorini; Vito Mancini; Antonio Luigi Pastore; Antonio Carbone; Luigi Cormio; Giuseppe Carrieri; Alessandro Antonelli
Journal:  J Clin Med       Date:  2020-06-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.